nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0837	0.216	CbGeAlD
Propiomazine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.0306	0.0788	CbGeAlD
Propiomazine—DRD1—nerve—peripheral nervous system neoplasm	0.0287	0.0739	CbGeAlD
Propiomazine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.0286	0.0737	CbGeAlD
Propiomazine—DRD1—ganglion—peripheral nervous system neoplasm	0.0283	0.0729	CbGeAlD
Propiomazine—HTR2C—ganglion—peripheral nervous system neoplasm	0.022	0.0567	CbGeAlD
Propiomazine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.0218	0.0562	CbGeAlD
Propiomazine—HTR2A—pons—peripheral nervous system neoplasm	0.0216	0.0555	CbGeAlD
Propiomazine—DRD2—nerve—peripheral nervous system neoplasm	0.017	0.0436	CbGeAlD
Propiomazine—DRD2—ganglion—peripheral nervous system neoplasm	0.0167	0.0431	CbGeAlD
Propiomazine—DRD1—brainstem—peripheral nervous system neoplasm	0.0123	0.0317	CbGeAlD
Propiomazine—HTR2A—nerve—peripheral nervous system neoplasm	0.0112	0.0288	CbGeAlD
Propiomazine—HTR2A—ganglion—peripheral nervous system neoplasm	0.011	0.0284	CbGeAlD
Propiomazine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.0097	0.22	CrCbGaD
Propiomazine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.00963	0.0248	CbGeAlD
Propiomazine—HTR2C—brainstem—peripheral nervous system neoplasm	0.00957	0.0246	CbGeAlD
Propiomazine—Triflupromazine—BCHE—peripheral nervous system neoplasm	0.00794	0.18	CrCbGaD
Propiomazine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00742	0.0191	CbGeAlD
Propiomazine—DRD2—brainstem—peripheral nervous system neoplasm	0.00728	0.0187	CbGeAlD
Propiomazine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00649	0.0167	CbGeAlD
Propiomazine—HTR2A—brainstem—peripheral nervous system neoplasm	0.0048	0.0124	CbGeAlD
Propiomazine—Chlorpromazine—BCHE—peripheral nervous system neoplasm	0.00383	0.0869	CrCbGaD
Propiomazine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.00366	0.00942	CbGeAlD
Propiomazine—DRD2—cerebellum—peripheral nervous system neoplasm	0.00359	0.00923	CbGeAlD
Propiomazine—Diltiazem—ABCB1—peripheral nervous system neoplasm	0.00349	0.0792	CrCbGaD
Propiomazine—Triflupromazine—ABCB1—peripheral nervous system neoplasm	0.00311	0.0706	CrCbGaD
Propiomazine—Fluphenazine—ABCB1—peripheral nervous system neoplasm	0.00239	0.0543	CrCbGaD
Propiomazine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.00237	0.00609	CbGeAlD
Propiomazine—Clomipramine—ABCB1—peripheral nervous system neoplasm	0.00219	0.0496	CrCbGaD
Propiomazine—Chlorprothixene—ABCB1—peripheral nervous system neoplasm	0.00218	0.0494	CrCbGaD
Propiomazine—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.00201	0.0457	CrCbGaD
Propiomazine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.00194	0.044	CrCbGaD
Propiomazine—Trifluoperazine—ABCB1—peripheral nervous system neoplasm	0.00191	0.0434	CrCbGaD
Propiomazine—Methadone—ABCB1—peripheral nervous system neoplasm	0.00191	0.0433	CrCbGaD
Propiomazine—Chlorpromazine—ABCB1—peripheral nervous system neoplasm	0.0015	0.034	CrCbGaD
Propiomazine—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000298	0.000525	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000297	0.000524	CbGpPWpGaD
Propiomazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000296	0.000521	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000295	0.00052	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000294	0.000519	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000293	0.000517	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000291	0.000512	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000289	0.000509	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000286	0.000504	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000285	0.000503	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000285	0.000502	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000284	0.000501	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000284	0.0005	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000281	0.000495	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000281	0.000495	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00028	0.000493	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000275	0.000485	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000273	0.000481	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000272	0.000479	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000268	0.000471	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000264	0.000465	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	0.000261	0.00046	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00026	0.000458	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00026	0.000458	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00026	0.000458	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000257	0.000452	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000253	0.000445	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000249	0.000439	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000249	0.000439	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000249	0.000439	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000248	0.000437	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	0.000245	0.000432	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000245	0.000431	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000239	0.000421	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00023	0.000405	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000229	0.000403	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000227	0.000401	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000226	0.000398	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000225	0.000397	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000225	0.000396	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000224	0.000395	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000224	0.000395	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000222	0.000392	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000222	0.000391	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000221	0.00039	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000219	0.000386	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000213	0.000375	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000212	0.000374	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000203	0.000358	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000202	0.000356	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	0.0002	0.000353	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000199	0.00035	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000198	0.000349	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000198	0.000348	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000197	0.000347	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000197	0.000346	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000196	0.000346	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000195	0.000344	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000195	0.000343	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000195	0.000343	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000193	0.00034	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000193	0.00034	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000192	0.000339	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000192	0.000338	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00019	0.000334	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000189	0.000333	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000187	0.00033	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000186	0.000328	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000184	0.000324	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000184	0.000324	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000183	0.000323	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000183	0.000322	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000181	0.000319	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00018	0.000318	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000179	0.000315	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000176	0.000311	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000176	0.000309	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000173	0.000305	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000172	0.000303	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000169	0.000298	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000169	0.000297	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000169	0.000297	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000168	0.000296	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000167	0.000295	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000166	0.000292	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000166	0.000292	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000165	0.000292	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000161	0.000283	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000159	0.00028	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000158	0.000279	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000156	0.000275	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000139	0.000245	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000138	0.000243	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000137	0.000241	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000135	0.000238	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000132	0.000232	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000131	0.000231	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000131	0.00023	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000129	0.000228	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000129	0.000227	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000127	0.000224	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000126	0.000222	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000125	0.000221	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000125	0.00022	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000124	0.000219	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000123	0.000218	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000123	0.000217	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000121	0.000214	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00012	0.000212	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000119	0.000211	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000119	0.00021	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000119	0.00021	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000119	0.00021	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000119	0.000209	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000118	0.000209	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000118	0.000207	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000117	0.000207	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000117	0.000207	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000117	0.000206	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000117	0.000206	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000117	0.000206	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000116	0.000205	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000116	0.000205	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000115	0.000203	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000115	0.000203	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000115	0.000203	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000114	0.000202	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000114	0.000201	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000113	0.0002	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000113	0.000199	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000112	0.000197	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000109	0.000192	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000107	0.000188	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000106	0.000186	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000104	0.000184	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000104	0.000183	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000103	0.000181	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000102	0.00018	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000101	0.000177	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.97e-05	0.000176	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.83e-05	0.000173	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.79e-05	0.000173	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.7e-05	0.000171	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.7e-05	0.000171	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.64e-05	0.00017	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.5e-05	0.000167	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.43e-05	0.000166	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.38e-05	0.000165	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.37e-05	0.000165	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.29e-05	0.000164	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.28e-05	0.000164	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.28e-05	0.000164	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.26e-05	0.000163	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.23e-05	0.000163	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.2e-05	0.000162	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.11e-05	0.000161	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.09e-05	0.00016	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.89e-05	0.000157	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.88e-05	0.000157	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.85e-05	0.000156	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.74e-05	0.000154	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.73e-05	0.000154	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.72e-05	0.000154	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.7e-05	0.000153	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.67e-05	0.000153	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.64e-05	0.000152	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.58e-05	0.000151	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.56e-05	0.000151	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.56e-05	0.000151	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.51e-05	0.00015	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.5e-05	0.00015	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.48e-05	0.000149	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.45e-05	0.000149	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.43e-05	0.000149	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.42e-05	0.000148	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.4e-05	0.000148	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.38e-05	0.000148	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.35e-05	0.000147	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.35e-05	0.000147	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.32e-05	0.000147	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.27e-05	0.000146	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.25e-05	0.000145	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.13e-05	0.000143	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.07e-05	0.000142	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.97e-05	0.00014	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.84e-05	0.000138	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.78e-05	0.000137	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.72e-05	0.000136	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.72e-05	0.000136	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.7e-05	0.000136	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.68e-05	0.000135	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.65e-05	0.000135	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.63e-05	0.000134	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.62e-05	0.000134	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.58e-05	0.000134	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.57e-05	0.000133	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.56e-05	0.000133	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.3e-05	0.000129	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.27e-05	0.000128	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.25e-05	0.000128	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.17e-05	0.000126	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.17e-05	0.000126	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.06e-05	0.000124	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.04e-05	0.000124	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.02e-05	0.000124	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7e-05	0.000123	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.95e-05	0.000123	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.93e-05	0.000122	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.91e-05	0.000122	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.86e-05	0.000121	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.82e-05	0.00012	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.73e-05	0.000119	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.68e-05	0.000118	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.58e-05	0.000116	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.56e-05	0.000116	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.54e-05	0.000115	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.52e-05	0.000115	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.46e-05	0.000114	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.44e-05	0.000114	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.44e-05	0.000113	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.22e-05	0.00011	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.14e-05	0.000108	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.06e-05	0.000107	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.95e-05	0.000105	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.95e-05	0.000105	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.69e-05	0.0001	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.49e-05	9.67e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	5.41e-05	9.53e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.4e-05	9.52e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.39e-05	9.5e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.37e-05	9.47e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.35e-05	9.44e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.3e-05	9.34e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.29e-05	9.32e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.25e-05	9.25e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.25e-05	9.25e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.16e-05	9.1e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.15e-05	9.08e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.14e-05	9.05e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.12e-05	9.02e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.07e-05	8.94e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.06e-05	8.91e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.03e-05	8.86e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.63e-05	8.17e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.56e-05	8.04e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.55e-05	8.02e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.54e-05	7.99e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.52e-05	7.97e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.48e-05	7.89e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.46e-05	7.87e-05	CbGpPWpGaD
